Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Mabwell (Shanghai) Bioscience Co., Ltd.
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
| Przychód (średnia) |
212.47 |
721.00 |
1,356.33 |
2,165.67 |
| Przychód Δ r/r |
0.00% |
239.34% |
88.12% |
59.67% |
| Przychód (min) |
151.44 |
708.91 |
1,293.38 |
2,144.25 |
| Przychód (max) |
258.81 |
733.09 |
1,460.80 |
2,187.08 |
| EBITDA (średnia) |
-212.47 |
-721.00 |
-1,356.33 |
-2,165.67 |
| EBIT (średnia) |
-212.47 |
-721.00 |
-1,356.33 |
-2,165.67 |
| EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
| Zysk netto (średni) |
-992.98 |
-705.28 |
-340.00 |
40.00 |
| Zysk netto % |
-467.35% |
-97.82% |
-25.07% |
1.85% |
| EPS (średnia) |
-2.45 |
-1.76 |
-0.98 |
0.15 |
| Liczba analityków (Przychody) |
3 |
2 |
3 |
2 |
| Liczba analityków (EPS) |
3 |
1 |
3 |
2 |
| symbol |
688062.SS |
688062.SS |
688062.SS |
688062.SS |